Related references
Note: Only part of the references are listed.Integrating Bayesian variable selection with Modular Response Analysis to infer biochemical network topology
Tapesh Santra et al.
BMC SYSTEMS BIOLOGY (2013)
Model-Based Analysis of HER Activation in Cells Co-Expressing EGFR, HER2 and HER3
Harish Shankaran et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Roles of p38 MAPKs in invasion and metastasis
Ivan del Barco Barrantes et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Edita Aksamitiene et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models
Fulvio Chiacchiera et al.
CANCER LETTERS (2012)
Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
Malabika Sen et al.
CLINICAL CANCER RESEARCH (2012)
Integrated experimental and model-based analysis reveals the spatial aspects of EGFR activation dynamics
Harish Shankaran et al.
MOLECULAR BIOSYSTEMS (2012)
EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK
Kelly L. Mueller et al.
TRANSLATIONAL ONCOLOGY (2012)
Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell lines
H. Li et al.
ADVANCES IN MEDICAL SCIENCES (2011)
Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells
Nicole Grabinski et al.
CELLULAR SIGNALLING (2011)
A multiscale modeling approach to investigate molecular mechanisms of pseudokinase activation and drug resistance in the HER3/ErbB3 receptor tyrosine kinase signaling network
Shannon E. Telesco et al.
MOLECULAR BIOSYSTEMS (2011)
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
Birgit Schoeberl et al.
CANCER RESEARCH (2010)
Cancer systems biology: a network modeling perspective
Pamela K. Kreeger et al.
CARCINOGENESIS (2010)
Kinase-mediated quasi-dimers of EGFR
Erez M. Bublil et al.
FASEB JOURNAL (2010)
ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
Fumin Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells
Yi Zhang et al.
BMC CELL BIOLOGY (2009)
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
Natalia Jura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
Birgit Schoeberl et al.
SCIENCE SIGNALING (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking
Harish Shankaran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Phosphatase-mediated crosstalk between MAPK signalling pathways in the regulation of cell survival
Melissa R. Junttila et al.
FASEB JOURNAL (2008)
System theoretical investigation of human epidermal growth factor receptor-mediated signalling
Y. Zhang et al.
IET SYSTEMS BIOLOGY (2008)
Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial Cells
Karin D. Rodland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells
Neil Kumar et al.
MOLECULAR PHARMACOLOGY (2008)
Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses
Marc R. Birtwistle et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
p38α -: A suppressor of cell proliferation and tumorigenesis
Lijian Hui et al.
CELL CYCLE (2007)
EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation
Elizabeth J. Joslin et al.
JOURNAL OF CELL SCIENCE (2007)
Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
Kazuko Sakai et al.
CANCER SCIENCE (2007)
Targeting HER proteins in cancer therapy and the role of the non-target HER3
A. C. Hsieh et al.
BRITISH JOURNAL OF CANCER (2007)
Regulation of MAPKs by growth factors and receptor tyrosine kinases
Menachem Katz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Small- and intermediate-conductance Ca2+-activated K+ channels directly control agonist-evoked nitric oxide synthesis in human vascular endothelial cells
Jian-Zhong Sheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate
Silvia D. M. Santos et al.
NATURE CELL BIOLOGY (2007)
Oncogenic re-wiring of cellular signaling pathways
T. Pawson et al.
ONCOGENE (2007)
A dimerization hierarchy in the transmembrane domains of the HER receptor family
Jean-Pierre Duneau et al.
BIOCHEMISTRY (2007)
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia V. Sergina et al.
NATURE (2007)
p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration
Mark R. Frey et al.
EMBO JOURNAL (2006)
ErbB-3 predicts survival in ovarian cancer
Berno Tanner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
被撤回的出版物: Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-κB in pancreatic cancer (Retracted article. See vol. 78, pg. 5477, 2018)
YX Zhang et al.
CANCER RESEARCH (2006)
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
JH Chen et al.
NATURE MEDICINE (2005)
Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface
JP Dawson et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Inference of signaling and gene regulatory networks by steady-state perturbation experiments: structure and accuracy
M Andrec et al.
JOURNAL OF THEORETICAL BIOLOGY (2005)
Phosphotyrosine interactome of the ErbB-receptor kinase family
Waltraud X. Schulze et al.
MOLECULAR SYSTEMS BIOLOGY (2005)
The activation of Akt/PKB signaling pathway and cell survival
G Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
The JAK/STAT signaling pathway
JS Rawlings et al.
JOURNAL OF CELL SCIENCE (2004)
ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface
MB Berger et al.
FEBS LETTERS (2004)
The erbB family: Targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors
EK Rowinsky
ANNUAL REVIEW OF MEDICINE (2004)
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
T Holbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression of the HERI-4 family of receptor tyrosine kinases in breast cancer
CJ Witton et al.
JOURNAL OF PATHOLOGY (2003)
ErbB-targeted therapeutic approaches in human cancer
CL Arteaga
EXPERIMENTAL CELL RESEARCH (2003)
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
A Citri et al.
EXPERIMENTAL CELL RESEARCH (2003)
The ErbB receptors and their role in cancer progression
T Holbro et al.
EXPERIMENTAL CELL RESEARCH (2003)
Epidermal growth factor receptor: mechanisms of activation and signalling
RN Jorissen et al.
EXPERIMENTAL CELL RESEARCH (2003)
Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers
L Yen et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Untangling the wires: A strategy to trace functional interactions in signaling and gene networks
BN Kholodenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
J Schlessinger
CELL (2002)
Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells
RM Neve et al.
ONCOGENE (2002)
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth
N Normanno et al.
ANNALS OF ONCOLOGY (2002)
Akt, MAPK (Erk1/2), and p38 act in concert to promote apoptosis in response to ErbB receptor family inhibition
JM Nelson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Construction of a genetic toggle switch in Escherichia coli
TS Gardner et al.
NATURE (2000)
Share Paper
